Actively Recruiting
Evaluating Platelet Lysate and Platelet-Rich Plasma Injections Compared to Placebo for Knee Osteoarthritis Pain and Function
Led by National Taiwan University Hospital · Updated on 2026-09-21
150
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating treatments for grade I to III knee osteoarthritis by comparing the effects of placebo, autologous platelet rich plasma PRP, and autologous platelet lysate PL injections. The study aims to find safer and more effective options than current temporary treatments like drugs and hyaluronic acid injections, potentially reducing medical costs and improving patients quality of life. Platelet lysate, a product containing growth factors and cytokines without white blood cells, may reduce inflammation and pain better than platelet rich plasma. Participants receive injections into the affected knee joint every 4 weeks for a total of 3 injections. The study includes three groups saline placebo injections, PRP injections, and PL injections, all delivered using the Aeon Acti-PRP device. This randomized, double-blind trial assesses and compares these interventions to evaluate their impact on knee osteoarthritis. During the study, participants are monitored for pain scores, knee function, and imaging results including X-rays and ultrasound up to 24 weeks after treatment. Researchers also track any adverse events to assess safety. The trial lasts until 24 weeks after treatment, with regular assessments to measure the treatments effects on symptoms and knee health.
CONDITIONS
Brief Title
Comparison of Effectiveness Between PL and PRP on Knee Osteoarthritis: a Prospective,Randomized,Placebo-controlled Trial
Research Team
W
WU Chueh-Hung, MD, CIPS
W
Wang Tyng-Guey, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here